Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Alle Kategorien

GUTEN ABEND: DAILY SMI -0,36% 13'765 SMI Top SIKA +2,9% UBSG +2,7% ABBN CFR +1,7% LOGN +1,1% GEBN +0,7% Flop ROP -2,7% NOVN -2,5% PGHN -2% KNIN -1,3% ALC -1,2% ZURN -0,5% +++ VSMI -1,55% 13.38 +++ DAX +0,37% 25’026 +++ Strasse freundlich bis fest
WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology » Report
Nestlé S.A.: Nescafé sources over 50% of its coffee supplies from farmers adopting regenerative agriculture practices in 2025 . » Report
Burckhardt Compression secures milestone order for first industrial scale Liquefied CO₂ carrier supporting Northern Lights CCS project » Report
BNS Considerazioni introduttive, conferenza stampa » Report
BNS Remarques introductives, conférence de presse » Report
SNB Einleitende Bemerkungen, Mediengespräch » Report
SNB Introductory remarks, news conference » Report
Monetary policy assessment of 18 June 2026 : Swiss National Bank leaves SNB policy rate unchanged at 0% » Report
Esame trimestrale del 18 giugno 2026 della situazione economica e monetaria : La Banca nazionale mantiene invariato il tasso guida BNS allo 0% » Report
Examen du 18 juin 2026 de la situation économique et monétaire : La BNS maintient son taux directeur à 0% » Report
Geldpolitische Lagebeurteilung vom 18. Juni 2026 : Nationalbank belässt SNB-Leitzins unverändert bei 0% » Report
Die Baupreise haben im April 2026 um 0,6% zugelegt » Report
Partners Group statement regarding Partners Group Private Equity Limited proposal » Report
SCHWEIZER INDIKATIONEN: Der SMI notiert vorbörslich leichter. Freundliche ABB, leichtere UBS, nachgebende Partners Group, schwache Amrize und Alcon, freundliche AMS Osram, VAT, Schindler, feste Leonteq fallen auf, leichter tendieren die übrigen Dividendenwerte. Quelle cash Insider
Mai 2026: Chemie-Pharma beschert Exporten kräftiges Plus » Report
Nestlé appoints Antonia Wanner as Chief Communications and Sustainability Officer » Report
FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma » Report
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma » Report
Leonteq AG Press release: Leonteq concludes regulatory legacy matters » Report